Lung cancer genetics study for young patients and families
Part of Cancer, Lungs & breathing clinical trials.
This study looks at genes that may affect lung cancer in people under 45 and their families. It aims to understand how lung cancer runs in families and improve future treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with non-small cell lung cancer (a common type of lung cancer).
- You were under 45 years old when you were diagnosed.
- At least one of your close relatives (parent, sibling, child, grandparent, grandchild, aunt, uncle, niece, or nephew) also has or had non-small cell lung cancer.
- You do not have another cancer that is currently being treated with chemotherapy or radiation therapy.
- You do not have a bleeding disorder (coagulopathy).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for inherited (family-passed) genetic changes that may raise the risk of lung cancer and related thoracic cancers. It may help people and families understand their genetic risk by collecting health information and sometimes specimens from patients and relatives.
This study looks at tissue samples from people with lung cancer to learn more about the genes and molecules that cause it. By participating, you may help doctors better understand lung cancer and improve future treatments.
This trial offers a low-dose chest CT scan to screen for lung cancer in family members of people with a specific genetic mutation driving their lung cancer. It aims to catch cancer early in those at higher risk.
This trial offers screening tests to look for lung cancer early in people whose parent, child, or sibling has had lung cancer. It may help find cancer sooner, when treatment is more effective.
This study builds and tests risk prediction tools for lung cancer in people who have never smoked, using information from family history. If it works, it may help doctors identify who might need closer screening earlier.
This study looks at biological samples from people diagnosed with lung cancer at age 45 or younger. It may help researchers understand how young lung cancers differ, which could guide future treatments.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.